T3D Therapeutics investigational agent

· T3D Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T3D Therapeutics investigational agent, covering 2018-07-30 to 2018-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]